Literature DB >> 15707844

Evidence for recombination in Candida glabrata.

Andrew R Dodgson1, Claude Pujol, Michael A Pfaller, David W Denning, David R Soll.   

Abstract

Despite its clinical importance, little is known of the epidemiology and population structure of Candida glabrata. C. glabrata possesses a mating type system similar to that in Saccharomyces cerevisiae, however mating, meiosis and recombination have not been demonstrated. We performed multilocus sequence typing on a collection of 165 isolates to test for evidence of genetic recombination. A total of 3345 bp from six loci (FKS, LEU2, NMT1, TRP1, UGP1, and URA3) were sequenced for each isolate. The polymorphisms at these loci defined 34 sequence types. Significant evidence for a clonal population was revealed by the index of association and the number of phylogenetically compatible pairs of loci. However, 14 examples of phylogenetic incompatibility were also found. Thus we conclude that although C. glabrata has a predominantly clonal population structure, the multiple phylogenetic incompatibilities found strongly suggest that recombination occurred during the evolution of C. glabrata, and may infrequently still occur.

Entities:  

Mesh:

Year:  2005        PMID: 15707844     DOI: 10.1016/j.fgb.2004.11.010

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  25 in total

Review 1.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Subtelomeric silencing of the MTL3 locus of Candida glabrata requires yKu70, yKu80, and Rif1 proteins.

Authors:  Candy Y Ramírez-Zavaleta; Griselda E Salas-Delgado; Alejandro De Las Peñas; Irene Castaño
Journal:  Eukaryot Cell       Date:  2010-07-30

3.  Large-Scale Chromosomal Changes and Associated Fitness Consequences in Pathogenic Fungi.

Authors:  Anja Forche
Journal:  Curr Fungal Infect Rep       Date:  2014-06-01

4.  Genotyping of Trypanosoma cruzi: systematic selection of assays allowing rapid and accurate discrimination of all known lineages.

Authors:  Michael D Lewis; Jonathan Ma; Matthew Yeo; Hernán J Carrasco; Martin S Llewellyn; Michael A Miles
Journal:  Am J Trop Med Hyg       Date:  2009-12       Impact factor: 2.345

5.  Multilocus microsatellite markers for molecular typing of Candida glabrata: application to analysis of genetic relationships between bloodstream and digestive system isolates.

Authors:  A Enache-Angoulvant; M Bourget; S Brisse; C Stockman-Pannier; L Diancourt; N François; D Rimek; C Fairhead; Daniel Poulain; C Hennequin
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

6.  Multilocus sequence type analysis reveals both clonality and recombination in populations of Candida glabrata bloodstream isolates from U.S. surveillance studies.

Authors:  Timothy J Lott; João P Frade; Shawn R Lockhart
Journal:  Eukaryot Cell       Date:  2010-02-26

7.  Organization and evolutionary trajectory of the mating type (MAT) locus in dermatophyte and dimorphic fungal pathogens.

Authors:  Wenjun Li; Banu Metin; Theodore C White; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2009-10-30

8.  Multiple-locus variable-number tandem-repeat analysis for rapid typing of Candida glabrata.

Authors:  Frédéric Grenouillet; Laurence Millon; Jean-Mathieu Bart; Sandrine Roussel; Isabelle Biot; Emeline Didier; Anne-Sophie Ong; Renaud Piarroux
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

Review 9.  Fungal sex and pathogenesis.

Authors:  Geraldine Butler
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Assessment of Candida glabrata strain relatedness by pulsed-field gel electrophoresis and multilocus sequence typing.

Authors:  Chi-Yang Lin; Yee-Chun Chen; Hsiu-Jung Lo; Kuo-Wei Chen; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2007-06-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.